Global Remdesivir Market Report By Dosage (5mg, 10 mg, 100mg), By Distribution Channel (Hospitals, Drug Stores, Others), By Patient Type (Adult, Pediatric, Geriatric), By Form, Lyophilized Powder, Concentrated Solution), By Application (Ebola, SARS-COV, MERS-COV) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Remdesivir Market Report
Brand: Value Market Research
SKU: Pharmaceuticals
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11214750

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Remdesivir Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Remdesivir is an antiviral medication with potential activity against a variety of RNA viruses. It was initially developed to treat hepatitis C but now has been widely adopted for coronavirus disease. Remdesivir shows a potential antiviral activity against the Ebola virus, MERS-CoV, and SARS-CoV. It works by inhibiting the virus from spreading in the body. Remdesivir comes as a solution or liquid and as a powder to be mixed with liquid and infused into a vein.

Market Dynamics

The global remdesivir market is witnessing dynamic growth. Demand for remdesivir has skyrocketed in last one year. Remdesivir is broadly used worldwide for treating severe novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) infection. Demand for remdesivir has increased worldwide amid the spike in daily cases of COVID-19. Growing investment and regulatory & government support are favoring the market growth. Attributed to booming demand, companies have ramped up their production rate and capacities. Meanwhile, shortage of supply, black market, and availability of other antiviral drugs substitute FabiFlu, Tocilizumab, and others are factors restraining the demand for Remdesivir. Moreover, health experts found that remdesevir does not hinder disease progression and is not helpful in any way during treatment, which is likely to reduce its use for treatment.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Remdesivir. The growth and trends of Remdesivir industry provide a holistic approach to this study.

Market Segmentation

This section of the Remdesivir market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Dosage

5mg
10mg
100mg

By Distribution Channel

Hospitals
Drug Stores
Others

By Patient Type

Adult
Pediatric
Geriatric

By Form

Lyophilized Powder
Concentrated Solution

By Application

Ebola
SARS-COV
MERS-COV

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Remdesivir market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Remdesivir Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Remdesivir market include Gilead Sciences, Inc., BrightGene Bio-Medical Technology Co., Ltd., Saptagir Laboratories Pvt. Ltd., Ferozsons Laboratories Limited, Mylan N.V., Hovione, Syngene, EVA PHARM, Zydus Cadila., Pfizer Inc., Dr. Reddy’s Laboratories Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot

3 . REMDESIVIR – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Dosage
           3.7.2 By Distribution Channel
           3.7.3 By Patient Type
           3.7.4 By Form
           3.7.5 By Application
           3.7.6 By Region

4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL REMDESIVIR MARKET ANALYSIS BY DOSAGE
       6.1 Overview by Dosage
       6.2 Historical and Forecast Data
       6.3 Analysis by Dosage
       6.4 5mg Market by Regions
       6.5 10 mg Market by Regions
       6.6 100mg Market by Regions

7 . GLOBAL REMDESIVIR MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Historical and Forecast Data
       7.3 Analysis by Distribution Channel
       7.4 Hospitals Market by Regions
       7.5 Drug stores Market by Regions
       7.6 Others Market by Regions

8 . GLOBAL REMDESIVIR MARKET ANALYSIS BY PATIENT TYPE
       8.1 Overview by Patient Type
       8.2 Historical and Forecast Data
       8.3 Analysis by Patient Type
       8.4 Adult Market by Regions
       8.5 Pediatric Market by Regions
       8.6 Geriatric Market by Regions

9 . GLOBAL REMDESIVIR MARKET ANALYSIS BY FORM
       9.1 Overview by Form
       9.2 Historical and Forecast Data
       9.3 Analysis by Form
       9.4 Lyophilized Powder Market by Regions
       9.5 Concentrated Solution Market by Regions

10 . GLOBAL REMDESIVIR MARKET ANALYSIS BY APPLICATION
       10.1 Overview by Application
       10.2 Historical and Forecast Data
       10.3 Analysis by Application
       10.4 Ebola Market by Regions
       10.5 SARS-COV Market by Regions
       10.6 MERS-COV Market by Regions
       10.7 COVID-19 Market by Regions

11 . GLOBAL REMDESIVIR MARKET ANALYSIS BY GEOGRAPHY
       11.1. Regional Outlook
       11.2. Introduction
       11.3. North America
           11.3.1. Overview, Historic and Forecast Data
           11.3.2. North America By Segment
           11.3.3. North America By Country
           11.3.4. United State
           11.3.5. Canada
           11.3.6. Mexico
       11.4. Europe
           11.4.1. Overview, Historic and Forecast Data
           11.4.2. Europe by Segment
           11.4.3. Europe by Country
           11.4.4. United Kingdom
           11.4.5. France
           11.4.6. Germany
           11.4.7. Italy
           11.4.8. Russia
           11.4.9. Rest Of Europe
       11.5. Asia Pacific
           11.5.1. Overview, Historic and Forecast Data
           11.5.2. Asia Pacific by Segment
           11.5.3. Asia Pacific by Country
           11.5.4. China
           11.5.5. India
           11.5.6. Japan
           11.5.7. South Korea
           11.5.8. Australia
           11.5.9. Rest Of Asia Pacific
       11.6. Latin America
           11.6.1. Overview, Historic and Forecast Data
           11.6.2. Latin America by Segment
           11.6.3. Latin America by Country
           11.6.4. Brazil
           11.6.5. Argentina
           11.6.6. Peru
           11.6.7. Chile
           11.6.8. Rest of Latin America
       11.7. Middle East & Africa
           11.7.1. Overview, Historic and Forecast Data
           11.7.2. Middle East & Africa by Segment
           11.7.3. Middle East & Africa by Country
           11.7.4. Saudi Arabia
           11.7.5. UAE
           11.7.6. Israel
           11.7.7. South Africa
           11.7.8. Rest Of Middle East And Africa

12 . COMPETITIVE LANDSCAPE OF THE REMDESIVIR COMPANIES
       12.1. Remdesivir Market Competition
       12.2. Partnership/Collaboration/Agreement
       12.3. Merger And Acquisitions
       12.4. New Product Launch
       12.5. Other Developments

13 . COMPANY PROFILES OF REMDESIVIR INDUSTRY
       13.1. Company Share Analysis
       13.2. Market Concentration Rate
       13.3. Gilead Sciences, Inc.
           13.3.1. Company Overview
           13.3.2. Financials
           13.3.3. Products
           13.3.4. Recent Developments
       13.4. BrightGene Bio-Medical Technology Co., Ltd.
           13.4.1. Company Overview
           13.4.2. Financials
           13.4.3. Products
           13.4.4. Recent Developments
       13.5. Saptagir Laboratories Pvt. Ltd.
           13.5.1. Company Overview
           13.5.2. Financials
           13.5.3. Products
           13.5.4. Recent Developments
       13.6. Ferozsons Laboratories Limited
           13.6.1. Company Overview
           13.6.2. Financials
           13.6.3. Products
           13.6.4. Recent Developments
       13.7. Mylan N.V.
           13.7.1. Company Overview
           13.7.2. Financials
           13.7.3. Products
           13.7.4. Recent Developments
       13.8. Hovione
           13.8.1. Company Overview
           13.8.2. Financials
           13.8.3. Products
           13.8.4. Recent Developments
       13.9. Syngene
           13.9.1. Company Overview
           13.9.2. Financials
           13.9.3. Products
           13.9.4. Recent Developments
       13.10. EVA PHARM
           13.10.1. Company Overview
           13.10.2. Financials
           13.10.3. Products
           13.10.4. Recent Developments
       13.11. Zydus Cadila
           13.11.1. Company Overview
           13.11.2. Financials
           13.11.3. Products
           13.11.4. Recent Developments
       13.12. Pfizer Inc.
           13.12.1. Company Overview
           13.12.2. Financials
           13.12.3. Products
           13.12.4. Recent Developments
       13.13. Dr. Reddy’s Laboratories Ltd.
           13.13.1. Company Overview
           13.13.2. Financials
           13.13.3. Products
           13.13.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Remdesivir Report
Market Research Process
Market Research Methodology
Global Remdesivir Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Dosage
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Patient Type
Market Attractiveness Analysis by Form
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Dosage (USD MN)
5mg Market by Geography (USD MN)
10 mg Market by Geography (USD MN)
100mg Market by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Hospitals Market by Geography (USD MN)
Drug stores Market by Geography (USD MN)
Others Market by Geography (USD MN)
Global Market Analysis by Patient Type (USD MN)
Adult Market by Geography (USD MN)
Pediatric Market by Geography (USD MN)
Geriatric Market by Geography (USD MN)
Global Market Analysis by Form (USD MN)
Lyophilized Powder Market by Geography (USD MN)
Concentrated Solution Market by Geography (USD MN)
Global Market Analysis by Application (USD MN)
Ebola Market by Geography (USD MN)
SARS-COV Market by Geography (USD MN)
MERS-COV Market by Geography (USD MN)
COVID-19 Market by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "